Studies related to Liver Enzymes and Perilla Oil

Perilla Oil And Exercise Decrease Expressions Of Tumor Necrosis Factor-alpha, Plasminogen Activator Inhibitor-1 And Highly Sensitive C-reactive Protein In Patients With Hyperlipidemia

Effect None
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 36
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Notes for this study:
Supplementation of perilla oil (dosage not specified) twice daily for 12 weeks in hyperlipidemic adults appeared to minorly benefit the lipid profile and inflammatory biomarkers in serum, with the potency being comparable to a mild exercise regimen (30-60 minutes four times a week of cardiovascular exercise, voluntary increases in intensity) but not additive. No placebo control, with benefit compared to baseline.